Impact of CBD-Rich Oil on Aversive Memory Reconsolidation

Status Recruiting

Clinical Trial Summary

The purpose of this study is to test whether cannabidiol (CBD) rich hemp extract oil can interfere with the reconsolidation (storage) of pathological fear memory in humans.

Clinical Trial Description

Preclinical experiments demonstrate that isolated cannabidiol (CBD), the non-psychotomimetic constituent of the Cannabis sativa plant, disrupts reconsolidation of aversive memories conditioned in the laboratory when administered within the memory reconsolidation window (< 6 hrs. post-retrieval) by indirectly activating cannabinoid type-1 (CB1) receptors in the dorsal anterior cingulate cortex (dACC). Furthermore, background material (e.g., terpenoids) naturally present in the cannabis plant may also disrupt aversive memory reconsolidation both alone and in concert with CBD. Based on these preclinical findings, we aim to test whether administration of 300mg CBD-rich hemp extract oil following fear reactivation of an aversive interoceptive threat memory can disrupt reconsolidation of naturalistic aversive memories in humans. More specifically, naturalistic interoceptive aversive memories, a form of transdiagnostic fear memory that contributes to the pathogenesis of fear-related disorders such as panic disorder, posttraumatic stress disorder (PTSD), and illness anxiety disorder. For this proof-of-concept double-blind trial, volunteers (n=96) reporting elevated fears of somatic sensations will be stratified on biological sex and baseline levels of interoceptive fear and randomized to one of three intervention arms: (a). CBD-rich oil administered within the reconsolidation window, (b). Placebo oil administered within the reconsolidation window, or (c). CBD-rich oil administered outside of the reconsolidation window. Change in emotional reactivity to a 35% CO2 challenge from baseline to two-week follow-up will serve as our primary outcome. Study findings may contribute towards the development of a novel ultra-brief transdiagnostic intervention guided by reconsolidation theory for individuals prone to fear-related psychiatric disorders. ;

Study Design

Related Conditions & MeSH terms

Anxiety and Fear

Clinical Trial Details

NCT number	NCT04726475
Study type	Interventional
Source	University of Texas at Austin
Contact	Michael J. Telch, PhD
Phone	5125604100
Email	telch@austin.utexas.edu
Status	Recruiting
Phase	Phase 1/Phase 2
Start date	January 2022
Completion date	January 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04027933` - Standard Patient Simulation in Nursing Students' Approach Toward Patients With Bipolar Disorder	N/A
Not yet recruiting	`NCT05614687` - Art as Healing: A Community-informed Art-based Programme (CiAbP) for Reintegrating Ex-offenders Into Society in Nigeria	N/A
Completed	`NCT05828264` - The Effect of "Quantum-Touch" on Pain, Fear, and Anxiety of the Children	N/A
Completed	`NCT04755998` - Evaluating the Effect of the Use of Virtual Reality Headset in School Vaccinations	N/A
Completed	`NCT04299555` - Assessment of Fears of Patients Standing at the Operating Block
Active, not recruiting	`NCT03993509` - Effect of rTMS on Anxiety	N/A
Completed	`NCT06011668` - EFFECT OF DISTRACTION METHODS ON PAIN AND ANXIETY DURING INTRAMUSCULAR INJECTION IN CHILDREN	N/A
Completed	`NCT05930015` - Effects of Music Combined With Sports Games on Alleviating Psychological Stress, Anxiety and Mental Energy Among Adolescents During COVID-19 Pandemic in Lanzhou Gansu Province China	N/A
Recruiting	`NCT06004115` - Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression	Phase 4
Recruiting	`NCT06257186` - Investigating the Effect of Art Therapy on Women With Fear of Childbirth During Pregnancy: A Mixed Method Study	N/A
Recruiting	`NCT03821779` - Prefrontal Oscillations in Social Anxiety Disorder (POSAD)	N/A
Completed	`NCT06336811` - Virtual Reality Distraction During Phlebotomy in Children	N/A
Recruiting	`NCT05548699` - Precision Mental Health in Diabetes - Subtypes of Mental Health, Trajectories, and Patterns With Glycaemic Control
Recruiting	`NCT04406181` - Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic	N/A
Completed	`NCT04821960` - Memory and Fear Study (Fear of Memory Loss Study)	N/A
Completed	`NCT06415188` - The Effect of Therapeutic Play on Pain, Fear, Anxiety and Physiological Parameters and Parents' Satisfaction	N/A
Completed	`NCT04631172` - Covid-19 Anxiety and Phobia Levels of the Parents
Active, not recruiting	`NCT04385732` - Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients	N/A
Recruiting	`NCT05469412` - Comparison of Pharmacological and Non-Pharmacological Interventions For Alleviating Preoperative Anxiety In Children	N/A
Completed	`NCT06189222` - The Effect of Virtual Reality Glasses Used During Intravenous Catheter Insertion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.